HOME >> BIOLOGY >> NEWS
From biodefense to prostate cancer offense

FOR IMMEDIATE RELEASE: (SACRAMENTO, Calif.) -- Two molecular geneticists at the UC Davis Cancer Center have won $1.1 million in grants to turn biodefense technology into a new prostate cancer offense. The grants were awarded by the U.S. Department of Defense Prostate Cancer Research Program.

Paul Gumerlock, professor of hematology/oncology, received a three-year, $557,000 grant to test a new gene-silencing method, developed last summer at Lawrence Livermore National Laboratory. Gumerlock will use the new method to silence certain DNA repair genes in prostate cancer cells. By doing so, he hopes to make the cancer cells more vulnerable to radiation therapy.

Philip Mack, a research geneticist, received a three-year, $334,000 grant to test the same gene-silencing method, known as siHybrid technology, against certain mutations of the p53 tumor suppressor gene. Mack will test whether silencing the mutations can help to prevent androgen independence, a poorly understood process that renders prostate cancer untreatable.

"Preventing or delaying the emergence of androgen independence, and perhaps even reversing it after it has occurred, would provide new treatment options and greatly impact overall patient survival," Mack says.

Gumerlock also received a second, 18-month grant for $111,000 to exploit two other biodefense technologies fresh from the Lawrence Livermore National Laboratory. One is a method of affixing cell-free DNA fragments to chips of glass, so the fragile fragments can be examined without being damaged. The other is a technique, known as in situ rolling circle amplification, which allows minute DNA fragments to be detected in the bloodstream with much greater sensitivity than previous methods.

Using the new techniques, Gumerlock intends to develop a blood test that can detect methylated, or deactivated, gene sequences common in prostate cancers. Methylation is a process commonly used by cancer cells to shut down tumo
'"/>

Contact: Claudia Morain
claudia.morain@ucdmc.ucdavis.edu
916 734-9023
University of California, Davis - Health System
4-May-2004


Page: 1 2

Related biology news :

1. PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
2. Project BioShield: Consistent financing, markets, indemnity for biodefense vaccine developers needed
3. ASM biodefense meeting scheduled for March 2003
4. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
5. Researchers identify distinctive signature for metastatic prostate cancer
6. Charting the future in prostate cancer care: A call to action
7. Study reveals first genetic step necessary for prostate cancer growth
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. MICs shed light on prostate cancer
10. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
11. New prostate cancer gene identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2019)... Calif. (PRWEB) , ... March 22, 2019 , ... ... Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary ... NGS market. The five-tube kit is comprised of preformatted master mixes for a ...
(Date:3/18/2019)... , ... March 18, 2019 , ... Periodontal disease, where ... loss, affects nearly 50% of the US population. Making this disease particularly challenging ... biofilm state, where the cells are enmeshed in a sticky extracellular material that makes ...
(Date:3/18/2019)... ... March 18, 2019 , ... ... leader in microbial solutions announce today they have entered into an agreement for ... breakthrough product for biologic nitrogen fixation for corn. This agreement ensures an easy-to-use ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ALISO VIEJO, Calif. (PRWEB) , ... March 19, ... ... subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the formation of their ... dedicated to the advancement of precision medicine that takes into account individual variability ...
(Date:3/15/2019)... PAULO and ATLANTA (PRWEB) , ... ... ... completed the acquisition of 100% equity in American Process Inc. and affiliate ... include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D ...
(Date:3/14/2019)... ... 2019 , ... Murrieta Genomics , the genomic sequencing business incubator, has ... business experience to bear as genomic sequencing startups build their business models. , “We ... that our Advisory Board brings to the table. Many of these experts would be ...
(Date:3/11/2019)... (PRWEB) , ... March 11, 2019 , ... In this ... considered to improve your clinical trial efficiency and experience. Participants will learn how to ... clinical IRT expertise to ensure that the simple or complex randomization scheme is properly ...
Breaking Biology Technology:
Cached News: